Royal Bank Of Canada Ac Immune Sa Transaction History

Royal Bank Of Canada

$458 Billion
Q1 2025

A detailed history of Royal Bank Of Canada transactions in Ac Immune Sa stock. As of the latest transaction made, Royal Bank Of Canada holds 1,660 shares of ACIU stock, worth $3,353. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,660

Previous 985 68.53%

Holding current value

$3,353

Previous $2,000 50.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.87 - $2.98 $1,262 - $2,011	675 Added 68.53%	1,660 $3,000
Q4 2024 Feb 14, 2025	BUY	$2.67 - $3.75 $600 - $843	225 Added 29.61%	985 $2,000
Q2 2024 Aug 14, 2024	SELL	$2.29 - $4.87 $2,809 - $5,975	-1,227 Reduced 61.75%	760 $3,000
Q1 2024 Nov 05, 2024	BUY	$2.66 - $4.87 $3,263 - $5,975	1,227 Added 161.45%	1,987 $5,000
Q1 2024 May 15, 2024	SELL	$2.66 - $4.87 $30,422 - $55,698	-11,437 Reduced 85.2%	1,987 $5,000
Q4 2023 Feb 14, 2024	BUY	$2.46 - $5.0 $26,191 - $53,235	10,647 Added 383.4%	13,424 $67,000
Q3 2023 Nov 14, 2023	SELL	$2.77 - $3.38 $1,445 - $1,764	-522 Reduced 15.82%	2,777 $7,000
Q2 2023 Aug 14, 2023	BUY	$1.85 - $3.4 $3,920 - $7,204	2,119 Added 179.58%	3,299 $9,000
Q4 2022 Feb 14, 2023	BUY	$1.72 - $3.12 $309 - $561	180 Added 18.0%	1,180 $2,000
Q3 2022 Nov 14, 2022	SELL	$2.4 - $3.64 $8,640 - $13,104	-3,600 Reduced 78.26%	1,000 $3,000
Q2 2022 Aug 15, 2022	SELL	$2.35 - $4.47 $5,170 - $9,834	-2,200 Reduced 32.35%	4,600 $17,000
Q1 2022 May 16, 2022	SELL	$3.5 - $5.16 $20,506 - $30,232	-5,859 Reduced 46.28%	6,800 $27,000
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $10,814 - $16,926	-2,239 Reduced 15.03%	12,659 $62,000
Q3 2021 Nov 15, 2021	SELL	$6.2 - $8.34 $657 - $884	-106 Reduced 0.71%	14,898 $100,000
Q2 2021 Aug 16, 2021	BUY	$6.04 - $8.37 $90,624 - $125,583	15,004 New	15,004 $119,000

Others Institutions Holding ACIU

# of Institutions

Shares Held

27.4M

Call Options Held

4.8K

Put Options Held

22.2K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $168M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Ac Immune Sa Transaction History